The Effect of Cooling With a Bed Topper and Linen on Itch in Clinical Routine
1 other identifier
interventional
15
1 country
1
Brief Summary
This single-blinded (only patients blinded) study is to assess the effect of cooling beddings on itch. The primary objective is to test whether or not the use of the cooling beddings during 3 days can add at least 20% improvement in (nocturnal) itch as measured by the 0-10 NRS in comparison to a control group that does not use the cooling beddings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2023
CompletedAugust 15, 2024
August 1, 2024
10 months
July 4, 2022
August 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
improvement in (nocturnal) itch
improvement in (nocturnal) itch as measured by the 0-10 Numeric rating Scale (NRS) (at least 2 NRS points per 24 hours to obtain a meaningful therapeutic benefit). (NRS, 0= no itch, 10= worst imaginable)
NRS ratings will be assessed every 6 hours (throughout 72 hours)
Secondary Outcomes (6)
Scratching activity measured by actigraph (Actigraph qGT3X-BT) on the dominant wrist
Continuously recorded throughout 72 hours
Richards-Campbell-Sleep Questionnaire (RCSQ) after each of the three nights addressing the sleep quality
Assessment after each night (3 times, altogether 72 hours)
Patient questionnaire (regarding lying comfort, cooling pleasantness)
One time assessment after the third night
Patient questionnaire regarding cooling intensity
One time assessment after the third night
Staff questionnaire regarding time practicability
Assessment after staff shift (3 times, altogether 72 hours)
- +1 more secondary outcomes
Study Arms (2)
interventional group: beddings with cooling effects
ACTIVE COMPARATORCooling beddings: linen made of the Outlast Technology https://www.outlast.com/en/. This product is made of 100 % lyocell and utilizes phase change materials based on natural wax. When this phase change material melts, heat is extracted from the environment and stored in microcapsules called thermocules. When the body cools down, these thermocules harden again release the heat from the linen. This might help to balances the body temperature and prevent warmth-aggravated itch. \- The mattress is made of polyurethane foam and designed as a "cool gel" topper to be placed onto the standard hospital mattress. Heat is also absorbed and stored into this topper. This topper is covered with an Obatex cover. It protects the "cool gel" topper from moisture and organic liquids and is made of polyamide fabric.
control group: commonly used bedding
PLACEBO COMPARATORInterventions
beddings with cooling effects (mattress topper and bed linen)
Eligibility Criteria
You may qualify if:
- Mean itch intensity NRS \> 5 in the past 3 days
- Literacy and ability to read
- Inpatient stay required for \> 3 nights
You may not qualify if:
- Age \< 18 years
- Illiteracy
- The duration of the hospitalisation is foreseen to be shorter than 3 days
- Para- and Tetraplegia
- Hemisensory syndrome
- Core body temperature \>38°C
- Use of other bedding \> 8 hours or 2nd time request
- Use of an occlusive therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, University Hospital Basel
Basel, 4031, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon Mueller, PD Dr. med.
Department of Dermatology, University Hospital Basel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- single-blinded (only patients blinded)
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2022
First Posted
July 15, 2022
Study Start
August 1, 2022
Primary Completion
May 28, 2023
Study Completion
May 28, 2023
Last Updated
August 15, 2024
Record last verified: 2024-08